Published

Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Biomedicines
Date: 2020-02-18
Source: PubMed
DOI: 10.3390/biomedicines8020034
PubMed: 32085521

Authors

Lewis CR Preller KH Braden BB Riecken C Vollenweider FX

Watch author

Derived topics and classifications

psilocybin psilocin Brain Imaging Receptor Pharmacology Consciousness Aging Emotional Processing Healthy Volunteers Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience.2020-02-18

Related papers

Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Open Label Psilocybin Brain Stimulation and Imaging Pilot StudyClinicalTrials.gov · 2026-08-07 A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-06-08 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy ParticipantsClinicalTrials.gov · 2025-06-12 A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy ParticipantsClinicalTrials.gov · 2024-10-09